Transcriptomic profiling from chronic lymphocytic leukemia patients successfully treated with CAR-T cells, revealed a general implementation of the IL-6/STAT3 signaling pathways, as indicated by increased production of IL-6, IL-17, IL-22, IL-31 and CCL20 [88,89]. The gene discussed is IL17A; the disease is B-cell chronic lymphocytic leukemia.